Erhielt zunächst den Glucagon-ähnlichen Peptid-1-Rezeptor-Agonisten (GLP-1-RA). Semaglutid Zulassung in Europa im Jahr 2018 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback